Drug Bureau Raids Illegal E-Cigarette Sales Points in China

Aug.22.2022
Drug Bureau Raids Illegal E-Cigarette Sales Points in China
Police seize illegal e-cigarette sales at three locations and arrest three people in Cambodia.

On August 21st, the Anti-Drug Administration conducted a surprise search of three locations selling illegal electronic cigarettes in Gandan Village, Shangding Province. Three individuals were arrested and 40 were detained.


Mr. Cham Panith, director of the Provincial Anti-Drug Office, has announced that after a police raid on three locations, illegal electronic cigarette products and various prohibited items were confiscated. Following product testing, all workers were forced to sign contracts to cease production and were dispersed to their homes. As for the owners of the three locations, authorities have detained them at the Upper Ding Province Police Station pending further legal action.


Statement


This article is compiled from information provided by a third party, and is intended solely for exchange and learning within the industry.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity or accuracy of the article's contents. The translation of this article is intended solely for the purpose of industry communication and research.


Due to limitations in the translation process, the translated article may not fully express the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any statements or positions regarding domestic issues, as well as those involving Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Ukraine intercepts approximately $40,000 worth of smuggled goods, including a large amount of Elfbar e-cigarettes
Ukraine intercepts approximately $40,000 worth of smuggled goods, including a large amount of Elfbar e-cigarettes
An e-cigarette smuggling operation was uncovered in the Lviv region of Ukraine, resulting in the seizure of 7,500 Elfbar e-cigarettes, valued at over 1.8 million hryvnia (approximately $40,000). The case is under investigation under Ukrainian criminal law.
Sep.23 by 2FIRSTS.ai
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
E-Cigarette Industry in Indonesia Expected to Create Up to 280,000 Jobs by 2030, Boosting Tax Revenue.
Sep.26 by 2FIRSTS.ai
B.C. Plans World’s First E-Cigarette Public Health Accountability Law Aimed at “Deceptive Marketing”
B.C. Plans World’s First E-Cigarette Public Health Accountability Law Aimed at “Deceptive Marketing”
British Columbia, Canada is advancing what it calls the world’s first e-cigarette Public Health Accountability law, granting the government authority to sue companies for “deceptive marketing.” The move puts public-health risks at the center of vaping industry compliance.
Oct.10 by 2FIRSTS.ai
FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores
FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores
FDA launches national retail compliance initiative to combat illegal e-cigarette sales targeting youth, issuing guidance materials to over 300k retailers.
Oct.08 by 2FIRSTS.ai